Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Soy supplement tested to curb asthma in babies

NCT ID NCT05667701

First seen Nov 21, 2025 · Last updated May 21, 2026 · Updated 24 times

Summary

This study tests whether a soy supplement (isoflavones) can reduce asthma risk in infants who have a genetic tendency to produce more of an inflammatory protein. 65 babies at high risk for asthma will receive either soy isoflavones or a placebo mixed into food twice daily for 7 months. Researchers will track wheezing episodes and lung function changes over one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA IN CHILDREN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ann and Robert H Lurie Childrens Hospital of Chicago

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact

    Contact Phone: •••-•••-••••

    Contact

  • Northwestern University Feinberg School of Medicine

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact

Conditions

Explore the condition pages connected to this study.